[1]
2026. E-Cadherin Immunohistochemical Expression as a Prognostic Biomarker in Colorectal Adenocarcinoma: Correlations with Clinicopathological Variables and Tumor Progression in AL-Beyda Medical Center. Razi Medical Journal. (Jun. 2026), 373–379. DOI:https://doi.org/10.69667/rmj.26231.